2012/01/01 by Fangfang Chao, Hong Zhang · 71 citations
Medicine · #Cancer #Computed tomography #Internal medicine #Lung #Lung Cancer Diagnosis and Treatment #Lung cancer #Medical Imaging Techniques and Applications #Medicine #Nuclear medicine #Oncology #PET-CT #Positron emission tomography #Radiology #Radiomics and Machine Learning in Medical Imaging
paper · pdf · doi:10.1155/2012/783739
published in BioMed Research International 2012, 1-8 (Hindawi Publishing Corporation)
openalex publication_date 2012/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Lung cancer is a common disease and the leading cause of cancer-related death in many countries. Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis. Positron emission tomography/computed tomography (PET/CT), combining anatomic information of CT and metabolic information of PET, is emerging as a potential diagnosis and staging test in patients with non-small-cell lung cancer (NSCLC). The purpose of this paper is to discuss the value of integrated PET/CT in the staging of the non-small-cell lung cancer and its health economics.